Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection

Microbes and Infection

Volumn 13, Issue 4, 2011, Pages 322-330

  Johanns, Tanner M ^a   Law, Calvin Y ^a   Kalekar, Lokeshchandra A ^a   O'Donnell, Hope ^a   Ertelt, James M ^a   Rowe, Jared H ^a   Way, Sing Sing ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antibiotic treatment; Recurrent infection; Salmonella

Indexed keywords

BACTERIUM ANTIBODY; ENROFLOXACIN; SALMONELLA ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY MEDIATED PROTECTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG WITHDRAWAL; ERADICATION THERAPY; FEMALE; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIMARY INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SECONDARY INFECTION; T CELL DEPLETION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLUOROQUINOLONES; IMMUNITY, HUMORAL; MALE; MICE; MICE, INBRED C57BL; SALMONELLA; SALMONELLA INFECTIONS; TIME FACTORS;

MURINAE; MUS; SALMONELLA;

EID: 79952443818     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.11.004     Document Type: Article

References (41)

1. Bhutta Z.A., Khan I.A., Shadmani M. Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan. Antimicrobial. Agents Chemother. 2000, 44:450-452.
2. Gotuzzo E., Morris J.G., Benavente L., Wood P.K., Levine O., Black R.E., Levine M.M. Association between specific plasmids and relapse in typhoid fever. J. Clin. Microbiol. 1987, 25:1779-1781.
3. Islam A., Butler T., Kabir I., Alam N.H. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial. Antimicrobial. Agents Chemother. 1993, 37:1572-1575.
4. Yew F.S., Chew S.K., Goh K.T., Monteiro E.H., Lim Y.S. Typhoid fever in Singapore: a review of 370 cases. J. Trop. Med. Hyg. 1991, 94:352-357.
5. Islam A., Butler T., Ward L.R. Reinfection with a different Vi-phage type of Salmonella typhi in an endemic area. The Journal of Infectious Diseases 1987, 155:155-156.
6. Wain J., Hien T.T., Connerton P., Ali T., Parry C.M., Chinh N.T., Vinh H., Phuong C.X., Ho V.A., Diep T.S., Farrar J.J., White N.J., Dougan G. Molecular typing of multiple-antibiotic-resistant Salmonella enterica serovar Typhi from Vietnam: application to acute and relapse cases of typhoid fever. J. Clin. Microbiol. 1999, 37:2466-2472.
7. Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Typhoid fever. N. Engl. J. Med. 2002, 347:1770-1782.
8. Dupont H.L., Hornick R.B., Snyder M.J., Dawkins A.T., Heiner G.G., Woodward T.E. Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection. Bull. World Health Organ. 1971, 44:667-672.
9. Marmion D.E., Naylor G.R., Stewart I.O. Second attacks of typhoid fever. J. Hyg. (Lond). 1953, 51:260-267.
10. Gaines S., Tully J.G., Tigertt W.D. Studies on infection and immunity in experimental typhoid fever. II. Susceptibility of recovered animals to re-exposure. J. Exp. Med. 1960, 112:1023-1036.
11. Hoiseth S.K., Stocker B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981, 291:238-239.
12. McSorley S.J., Jenkins M.K. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infect. Immun. 2000, 68:3344-3348.
13. Griffin A., Baraho-Hassan D., McSorley S.J. Successful treatment of bacterial infection hinders development of acquired immunity. J. Immunol. 2009, 183:1263-1270.
14. Luu R.A., Gurnani K., Dudani R., Kammara R., van Faassen H., Sirard J.C., Krishnan L., Sad S. Delayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium. J. Immunol. 2006, 177:1516-1525.
15. Mittrucker H.W., Kohler A., Kaufmann S.H. Characterization of the murine T-lymphocyte response to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2002, 70:199-203.
16. Johanns T.M., Ertelt J.M., Rowe J.H., Way S.S. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathogens 2010, 6.
17. McSorley S.J., Asch S., Costalonga M., Reinhardt R.L., Jenkins M.K. Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 2002, 16:365-377.
18. Johanns T.M., Ertelt J.M., Lai J.C., Rowe J.H., Avant R.A., Way S.S. Naturally occurring altered peptide ligands control Salmonella-specific CD4+ T cell proliferation, IFN-gamma production, and protective potency. J. Immunol. 2010, 184:869-876.
19. Srinivasan A., Nanton M., Griffin A., McSorley S.J. Culling of activated CD4 T cells during typhoid is driven by Salmonella virulence genes. J. Immunol. 2009, 182:7838-7845.
20. Cunningham A.F., Gaspal F., Serre K., Mohr E., Henderson I.R., Scott-Tucker A., Kenny S.M., Khan M., Toellner K.M., Lane P.J., MacLennan I.C. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J. Immunol. 2007, 178:6200-6207.
21. Guilloteau L., Buzoni-Gatel D., Bernard F., Lantier I., Lantier F. Salmonella abortusovis infection in susceptible BALB/cby mice: importance of Lyt-2+ and L3T4+ T cells in acquired immunity and granuloma formation. Microb. Pathog. 1993, 14:45-55.
22. Hess J., Ladel C., Miko D., Kaufmann S.H. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J. Immunol. 1996, 156:3321-3326.
23. Lo W.F., Ong H., Metcalf E.S., Soloski M.J. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 1999, 162:5398-5406.
24. Nauciel C. Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J. Immunol. 1990, 145:1265-1269.
25. Sinha K., Mastroeni P., Harrison J., de Hormaeche R.D., Hormaeche C.E. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect. Immun. 1997, 65:1566-1569.
26. Weintraub B.C., Eckmann L., Okamoto S., Hense M., Hedrick S.M., Fierer J. Role of alphabeta and gammadelta T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined Ity genotypes. Infect. Immun. 1997, 65:2306-2312.
27. Eisenstein T.K., Killar L.M., Sultzer B.M. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. The Journal of Infectious Diseases 1984, 150:425-435.
28. Collins F.M. Vaccines and cell-mediated immunity. Bacteriol. Rev. 1974, 38:371-402.
29. Acharya I.L., Lowe C.U., Thapa R., Gurubacharya V.L., Shrestha M.B., Cadoz M., Schulz D., Armand J., Bryla D.A., Trollfors B., et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N. Engl. J. Med. 1987, 317:1101-1104.
30. Fraser A., Paul M., Goldberg E., Acosta C.J., Leibovici L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 2007, 25:7848-7857.
31. Klugman K.P., Gilbertson I.T., Koornhof H.J., Robbins J.B., Schneerson R., Schulz D., Cadoz M., Armand J. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987, 2:1165-1169.
32. Levine M.M., Tacket C.O., Sztein M.B. Host-Salmonella interaction: human trials. Microbes Infect. 2001, 3:1271-1279.
33. Yang H.H., Wu C.G., Xie G.Z., Gu Q.W., Wang B.R., Wang L.Y., Wang H.F., Ding Z.S., Yang Y., Tan W.S., Wang W.Y., Wang X.C., Qin M., Wang J.H., Tang H.A., Jiang X.M., Li Y.H., Wang M.L., Zhang S.L., Li G.L. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull. World Health Organ. 2001, 79:625-631.
34. Mastroeni P., Simmons C., Fowler R., Hormaeche C.E., Dougan G. Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect. Immun. 2000, 68:46-53.
35. Mittrucker H.W., Raupach B., Kohler A., Kaufmann S.H. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J. Immunol. 2000, 164:1648-1652.
36. Ugrinovic S., Menager N., Goh N., Mastroeni P. Characterization and development of T-Cell immune responses in B-cell-deficient (Igh-6(-/-)) mice with Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2003, 71:6808-6819.
37. Killar L.M., Eisenstein T.K. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infect. Immun. 1985, 47:605-612.
38. Mastroeni P., Villarreal-Ramos B., Hormaeche C.E. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect. Immun. 1993, 61:3981-3984.
39. Rajagopalan P., Kumar R., Malaviya A.N. A study of humoral and cell-mediated immune response following typhoid vaccination in human volunteers. Clin. Exp. Immunol. 1982, 47:275-282.
40. Rajagopalan P., Kumar R., Malaviya A.N. Immunological studies in typhoid fever. II. Cell-mediated immune responses and lymphocyte subpopulations in patients with typhoid fever. Clin. Exp. Immunol. 1982, 47:269-274.
41. Sarma V.N., Malaviya A.N., Kumar R., Ghai O.P., Bakhtary M.M. Development of immune response during typhoid fever in man. Clin. Exp. Immunol. 1977, 28:35-39.